Collagen Type III

Type III collagen is a homotrimer of three identical alpha-1 chains encoded by COL3A1. It forms thinner fibrils than type I and co-polymerises with it, and the proportion of type III within a mixed fibril is one determinant of final fibril diameter. It is abundant where compliance matters more than tensile strength: arterial walls, gut, uterus, fetal skin, and the loose provisional matrix of a fresh wound. Because it is deposited quickly and needs less organisation, it is the collagen of early repair, and the type III to type I ratio falls over weeks to months as scar matures.

The clinical anchor is vascular Ehlers-Danlos syndrome, caused by COL3A1 mutations, in which arterial, bowel and uterine rupture occur in tissue that looks structurally normal. In the musculoskeletal setting the observation runs the other way: chronically tendinopathic and surgically repaired tendon retains an elevated type III fraction long after healing is nominally complete, and that type III-rich matrix is part of why repaired tendon stays weaker than tendon never injured.

This flips the sign on a common inference. In tendon, more type III is not evidence of better healing; it is evidence of scar. Favourable remodelling looks like a falling type III share, larger and more variable fibril diameters, and restored fibre alignment.

The practical trap is timing. The ratio changes substantially on its own across the first weeks after injury, so treated and untreated animals sampled at slightly different points on the healing curve will differ regardless of any drug effect. Single-timepoint rodent data showing a shifted ratio are therefore weak evidence at best, and vendor material citing such a shift as proof of accelerated tendon healing is reading a normal maturation curve as a treatment response.